Evidence map›Paper›PMID 26124206›Full record

ReviewJournal of the American Heart Association2015

Rho-GTPase and Atherosclerosis: Pleiotropic Effects of Statins.

Anping Cai, Yingling Zhou, Liwen Li

Abstract readReview
In one paragraph

Review in Journal of the American Heart Association, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed.

  1. Trial
  2. Review
  3. Review
  4. Article
  5. The Role of miR-144 in Inflammatory Diseases: A Review.Immunity, inflammation and disease · 2025
    Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. [Rho kinase inhibitors as new local therapy option in primary open angle glaucoma].Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft · 2021
    Review
  12. Review
  13. Article
  14. Role of Macrophages and RhoA Pathway in Atherosclerosis.International journal of molecular sciences · 2020
    Review
  15. Pleiotropic effects of statins: A focus on cancer.Biochimica et biophysica acta. Molecular basis of disease · 2020
    Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Anping CaiDepartment of Cardiology, Guangdong Cardiovascular Institute, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China (A.C., Y.Z., L.L.).
Yingling ZhouDepartment of Cardiology, Guangdong Cardiovascular Institute, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China (A.C., Y.Z., L.L.).
Liwen LiDepartment of Cardiology, Guangdong Cardiovascular Institute, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China (A.C., Y.Z., L.L.).

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsAnti-Inflammatory AgentsAntioxidantsArteriesAtherosclerosisDisease ProgressionDrug Therapy, CombinationHumansHydroxymethylglutaryl-CoA Reductase InhibitorsPlaque, AtheroscleroticPlatelet Aggregation InhibitorsProtein Kinase Inhibitorsrho-Associated Kinasesrho GTP-Binding ProteinsSignal TransductionTreatment OutcomeAnti-Inflammatory AgentsAntioxidantsHydroxymethylglutaryl-CoA Reductase InhibitorsPlatelet Aggregation InhibitorsProtein Kinase Inhibitorsrho-Associated Kinasesrho GTP-Binding Proteinsatherosclerotic cardiovascular diseasesRho‐GTPasestatins

Identifiers

PMID26124206
PMCPMC4608090

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.